Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adderall XR 20mg capsules
0404000L0BFAEAF
|
Adderall | Dexamfetamine sulfate | Central Nervous System | 10 |
|
Adderall 10mg tablets
0404000L0BFAAAV
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 10mg capsules
0404000L0BFAFBH
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 15mg capsules
0404000L0BFAHBE
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 25mg capsules
0404000L0BFAIBF
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 30mg capsules
0404000L0BFADAY
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Adderall XR 5mg capsules
0404000L0BFAGBD
|
Adderall | Dexamfetamine sulfate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.